|
1 Introduction To The Lymph Node |
|
|
1 | (36) |
|
|
2 | (10) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
3 | (5) |
|
|
8 | (1) |
|
|
9 | (3) |
|
|
12 | (5) |
|
|
12 | (1) |
|
|
12 | (2) |
|
|
14 | (3) |
|
|
17 | (3) |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
17 | (3) |
|
|
20 | (5) |
|
|
20 | (3) |
|
|
23 | (1) |
|
|
23 | (2) |
|
|
25 | (12) |
|
IgG4-Reactive Lymphadenopathy |
|
|
25 | (1) |
|
Nodal Marginal Zone B-Cell Lymphoma With Colonization of Reactive Follicles |
|
|
25 | (2) |
|
Intrafollicular Neoplasia |
|
|
27 | (4) |
|
Interfollicular Classical Hodgkin Lymphoma |
|
|
31 | (1) |
|
Early Angioimmunoblastic T-cell Lymphoma |
|
|
31 | (6) |
|
|
37 | (26) |
|
Normal Lymph Node Capsule |
|
|
38 | (1) |
|
|
38 | (1) |
|
Lymph Node Versus Lymphoid Tissue |
|
|
38 | (1) |
|
|
38 | (1) |
|
|
39 | (1) |
|
|
40 | (15) |
|
|
40 | (9) |
|
|
49 | (6) |
|
|
55 | (8) |
|
Angioimmunoblastic T-cell Lymphoma |
|
|
55 | (1) |
|
|
55 | (2) |
|
Tumor-Infiltrating Lymphocytes Versus Metastatic Disease |
|
|
57 | (1) |
|
Capsular Nevi Versus Metastatic Melanoma |
|
|
57 | (6) |
|
|
63 | (22) |
|
|
64 | (1) |
|
Conditions With Dilated Prominent Sinuses |
|
|
64 | (5) |
|
Sinus Histiocytosis and Dermatopathic Lymphadenopathy |
|
|
64 | (1) |
|
Sinus Histiocytosis With Massive Lymphadenopathy (SHML) |
|
|
65 | (1) |
|
Langerhans Cell Histiocytosis (LCH) |
|
|
65 | (1) |
|
Lymphoplasmacytic Lymphoma |
|
|
66 | (1) |
|
Node Draining Suppurative Area |
|
|
67 | (1) |
|
Lipid-Associated Lymphadenopathy (Lymphangiogram, Prosthesis, or Storage Diseases) |
|
|
67 | (1) |
|
Vascular Transformation of Sinuses |
|
|
68 | (1) |
|
|
69 | (1) |
|
Sinusoidal Involvement by Kaposi Sarcoma Mimicking Vascular Transformation of Sinuses |
|
|
69 | (1) |
|
Sinusoidal Lymphomatous Infiltrates |
|
|
69 | (1) |
|
|
70 | (5) |
|
ALCL Mimicking Metastatic Carcinoma |
|
|
70 | (4) |
|
|
74 | (1) |
|
|
75 | (2) |
|
|
75 | (1) |
|
|
75 | (1) |
|
Other Perisinusoidal Cellular Clusters |
|
|
76 | (1) |
|
Conditions With Inconspicuous/Obliterated Sinuses |
|
|
77 | (8) |
|
|
77 | (2) |
|
|
79 | (1) |
|
Angioimmunoblastic T-cell Lymphoma |
|
|
80 | (5) |
|
|
85 | (22) |
|
|
86 | (1) |
|
|
86 | (1) |
|
Site-Specific Variations in Follicles |
|
|
86 | (1) |
|
|
87 | (9) |
|
Reactive Follicular Hyperplasia |
|
|
87 | (1) |
|
Giant Follicular Hyperplasia |
|
|
88 | (4) |
|
Reactive Follicular Hyperplasia In Altered Immune States |
|
|
92 | (1) |
|
Intrafollicular Plasmacytosis-IgG4 Disease |
|
|
93 | (2) |
|
Other Clonal Conditions With Reactive Hyperplasia |
|
|
95 | (1) |
|
Abnormal Expanded Mantle Zones |
|
|
96 | (6) |
|
Castleman-Like Proliferations |
|
|
96 | (3) |
|
Progressive Transformation of Germinal Centers |
|
|
99 | (2) |
|
|
101 | (1) |
|
|
102 | (1) |
|
Other Infectious Processes |
|
|
102 | (5) |
|
|
102 | (5) |
|
|
107 | (48) |
|
|
108 | (15) |
|
Dermatopathic Lymphadenopathy |
|
|
108 | (3) |
|
|
111 | (9) |
|
Drug-Associated Lymphadenopathy |
|
|
120 | (2) |
|
|
122 | (1) |
|
Systemic Lupus Erythematosus Lymphadenopathy |
|
|
122 | (1) |
|
Atypical Paracortical Hyperplasia |
|
|
122 | (1) |
|
Histiocytic Proliferations |
|
|
123 | (7) |
|
|
123 | (4) |
|
|
127 | (1) |
|
|
127 | (3) |
|
|
130 | (5) |
|
|
130 | (5) |
|
Abnormalities of Vessel Walls |
|
|
135 | (1) |
|
Expansion/Infiltration of the Paracortex by Unexpected Cells |
|
|
135 | (11) |
|
Atypical Lymphocytes/Lymphomas |
|
|
137 | (1) |
|
|
137 | (7) |
|
|
144 | (2) |
|
|
146 | (1) |
|
|
146 | (9) |
|
Hamazaki-Wesenberg Bodies in Sarcoidosis Lymphadenopathy |
|
|
146 | (2) |
|
Indolent "[ "-Lymphoblastic Proliferation |
|
|
148 | (1) |
|
Lymph Node Involvement by Myeloid/Lymphoid Neoplasms With PDGFRA Rearrangement |
|
|
148 | (7) |
|
6 Obliterated Nodular Pattern |
|
|
155 | (24) |
|
|
156 | (1) |
|
List of Entities to Consider in Cases With Nodular Pattern |
|
|
156 | (1) |
|
|
157 | (11) |
|
Some Histologic Variations That Represent Pitfalls in the Diagnosis of Follicular Lymphoma |
|
|
157 | (5) |
|
Grading and Follicular Lymphoma |
|
|
162 | (3) |
|
Unconventional Wisdom Relating to FL Grading |
|
|
165 | (3) |
|
Immunostains and Approach in Nodular Proliferations |
|
|
168 | (5) |
|
Scenarios and Clinical Details That Determine How You Look at and Sign Out Some Follicular Lymphoma Cases |
|
|
172 | (1) |
|
Pitfall Cases of Nodular Proliferations |
|
|
173 | (6) |
|
Pitfall Case 1: Nodal Marginal Zone lymphoma with Follicular Colonization |
|
|
173 | (2) |
|
Pitfall Case 2: Germinotropic lymphoproliferative disorder, EBV+/ HHV8+ |
|
|
175 | (1) |
|
Pitfall Case 3: Follicular variant of peripheral T-cell lymphoma (Figures 6.66-6.70) |
|
|
176 | (3) |
|
7 Obliterated Nodal Architecture |
|
|
179 | (42) |
|
|
180 | (18) |
|
Small Lymphocytic Lymphoma and Richter Syndrome |
|
|
180 | (3) |
|
|
183 | (1) |
|
Diffuse Follicular Lymphoma |
|
|
183 | (2) |
|
Follicular Lymphoma With Transformation to DLBCL |
|
|
185 | (1) |
|
Plasmacytoma/Plasma Cell Myeloma |
|
|
186 | (1) |
|
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified |
|
|
187 | (1) |
|
T-Cell-/Histiocyte-Rich Large B-Cell Lymphoma |
|
|
188 | (1) |
|
|
189 | (3) |
|
Primary Mediastinal Large B-Cell Lymphoma |
|
|
192 | (1) |
|
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma (Gray Zone Lymphoma) |
|
|
192 | (1) |
|
|
192 | (1) |
|
High-Grade B-Cell Lymphoma |
|
|
193 | (5) |
|
|
198 | (8) |
|
Anaplastic Large-Cell Lymphoma |
|
|
198 | (1) |
|
Peripheral T-Cell Lymphoma |
|
|
198 | (4) |
|
Lymphoepithelioid Variant of PTCL (Lennert Lymphoma) |
|
|
202 | (4) |
|
|
206 | (3) |
|
|
206 | (3) |
|
|
209 | (1) |
|
|
209 | (1) |
|
|
209 | (12) |
|
Blastoid Variant of Mantle Cell Lymphoma |
|
|
209 | (4) |
|
Nodal Involvement by CD30-Positive T-Cell Lymphoproliferative Disorder |
|
|
213 | (1) |
|
Peripheral T-Cell Lymphoma With Hodgkin-Like Cells |
|
|
213 | (3) |
|
Anaplastic Large-Cell Lymphoma With Aberrant Expression of PAX5 |
|
|
216 | (5) |
|
|
221 | (20) |
|
|
222 | (1) |
|
Lymphoma/Aggressive Lymphoproliferative Neoplasms |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
222 | (6) |
|
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified |
|
|
223 | (1) |
|
EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified |
|
|
223 | (2) |
|
Post-Transplant Lymphoproliferative Disorder |
|
|
225 | (2) |
|
|
227 | (1) |
|
Classical Hodgkin Lymphoma |
|
|
228 | (1) |
|
T-Cell and NK Cell Lymphoma |
|
|
228 | (1) |
|
Peripheral T-Cell Lymphoma, Not Otherwise Specified |
|
|
228 | (1) |
|
|
228 | (1) |
|
Anaplastic Large Cell Lymphoma |
|
|
229 | (3) |
|
|
232 | (4) |
|
Mycobacterial Lymphadenitis |
|
|
232 | (1) |
|
Cytomegalovirus Infection |
|
|
233 | (1) |
|
Herpes Simplex Lymphadenitis |
|
|
233 | (1) |
|
|
233 | (1) |
|
Fungal Infection/Lymphadenitis |
|
|
234 | (2) |
|
Benign Reactive Lymphoproliferative Disorders |
|
|
236 | (1) |
|
Systemic Lupus Erythematosus |
|
|
236 | (1) |
|
|
236 | (5) |
|
Epstein-Barr Virus: Infectious Mononucleosis |
|
|
236 | (1) |
|
Kikuchi-Fujimoto Lymphadenitis |
|
|
236 | (5) |
|
|
241 | (36) |
|
|
242 | (1) |
|
Key Features Related to Technical Points in Immunohistochemistry |
|
|
242 | (1) |
|
List of Common Antibodies in Lymphoma Immunohistochemistry |
|
|
243 | (2) |
|
|
245 | (25) |
|
CD20-Negative Follicular Lymphoma |
|
|
245 | (9) |
|
Incidental Mantle Cell Lymphoma in Reactive Looking Node |
|
|
254 | (4) |
|
Peripheral T-cell Lymphoma With Hodgkin-Like Cells of B-Cell Derivation |
|
|
258 | (6) |
|
Stains Related to Microorganisms |
|
|
264 | (2) |
|
Extracavitary Primary Effusion Lymphoma |
|
|
266 | (4) |
|
Exercise in Interpretation, Sample Write-Ups in One Single Case, and Best Practices in Write-Ups |
|
|
270 | (7) |
Self-Assessment Questions |
|
277 | (12) |
Self-Assessment Answers |
|
289 | (8) |
Index |
|
297 | |